Mark Brosius Biography and Net Worth

Mark P. Brosius is senior vice president and chief manufacturing and supply chain officer at Intuitive, with responsibility for SIOP, supply chain, new product introduction, manufacturing, and logistics operations. Brosius is a leading expert in enterprise scale manufacturing and business process automation, as well as the application of big data and analytics to planning, supply chain, and manufacturing. He brings more than 30 years of experience in multinational manufacturing operations and product development.

Brosius joined Intuitive in 2012 as the founding leader of the manufacturing automation function, before leading new product introduction (NPI) engineering and ultimately all of operations. He was promoted to his current role in 2023.

Prior to joining Intuitive, he served as president and chief technology officer for Harbor Fluid Products, from 2002 to 2011.

Brosius earned a BS in mechanical engineering from Stanford University and completed graduate studies in finance at the University of California, Berkeley. He also holds an honorary degree in engineering management from California Polytechnic University at San Luis Obispo.

What is Mark Brosius' net worth?: The estimated net worth of Mark Brosius is at least $552,972.00 as of March 7th, 2024. Mr. Brosius owns 1,450 shares of Intuitive Surgical stock worth more than $552,972 as of May 3rd. This net worth approximation does not reflect any other investments that Mr. Brosius may own. Learn More about Mark Brosius' net worth.
How do I contact Mark Brosius?: The corporate mailing address for Mr. Brosius and other Intuitive Surgical executives is 1020 KIFER ROAD, SUNNYVALE CA, 94086. Intuitive Surgical can also be reached via phone at (408) 523-2100 and via email at [email protected]. Learn More on Mark Brosius' contact information.
Has Mark Brosius been buying or selling shares of Intuitive Surgical?: Mark Brosius has not been actively trading shares of Intuitive Surgical in the last ninety days. Most recently, Mark Brosius sold 196 shares of the business's stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $393.30, for a transaction totalling $77,086.80. Following the completion of the sale, the senior vice president now directly owns 1,450 shares of the company's stock, valued at $570,285. Learn More on Mark Brosius' trading history.
Who are Intuitive Surgical's active insiders?: Intuitive Surgical's insider roster includes Craig Barratt (Director), Mark Brosius (SVP), Myriam Curet (EVP), Myriam Curet (EVP), Robert DeSantis (EVP), Gary Guthart (CEO), Amal Johnson (Director), Amy Ladd (Director), Keith Leonard (Director), Alan Levy (Director), Marshall Mohr (CFO), Kara Reiter (SVP), David Rosa (EVP), Mark Rubash (Director), Jamie Samath (SVP), and Fredrik Widman (VP). Learn More on Intuitive Surgical's active insiders.
Are insiders buying or selling shares of Intuitive Surgical?: During the last year, insiders at the medical equipment provider sold shares 35 times. They sold a total of 387,887 shares worth more than $139,062,984.80. The most recent insider tranaction occured on April, 29th when EVP Robert Desantis sold 376 shares worth more than $141,146.64. Insiders at Intuitive Surgical own 0.9% of the company. Learn More about insider trades at Intuitive Surgical.
Information on this page was last updated on 4/29/2024.

Mark Brosius Insider Trading History at Intuitive Surgical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/7/2024	Sell	196	$393.30	$77,086.80	1,450
3/5/2024	Sell	196	$400.00	$78,400.00	1,842
2/16/2024	Sell	32	$378.29	$12,105.28	709
2/14/2024	Sell	30	$380.09	$11,402.70	771
2/12/2024	Sell	30	$386.09	$11,582.70	831
2/1/2024	Sell	39	$378.41	$14,757.99	448

Mark Brosius Buying and Selling Activity at Intuitive Surgical

Intuitive Surgical Company Overview

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Today's Range

Now: $381.36

$378.87

$384.47

50 Day Range

MA: $385.56

$366.34

$400.59

2 Week Range

Now: $381.36

$254.85

$403.76

Volume

1,028,827 shs

Average Volume

1,492,254 shs

Market Capitalization

$135.27 billion

P/E Ratio

68.84

Dividend Yield

N/A

Beta

1.39

Global crypto currency reset (41 major banks signed up)

From Stansberry Research | Ad

Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...

Here's everything you need to know.